Skip to main content

Your search for “immunotherapy” returned 120 results

Supercomputer Simulations Help Combat Tuberculosis (TB) Granulomas

March 20, 2019

Researchers from the University of Michigan relied on supercomputers at UC San Diego and elsewhere to help them develop detailed models to better understand how TB spreads throughout the lungs.

A New Strategy for Prevention of Liver Cancer Development

November 14, 2017

Primary liver cancer is now the second leading cause of cancer-related death worldwide, and its incidences and mortality are increasing rapidly in the United Stated. In late stages of the malignancy, there are no effective treatments or drugs. However, an unexpected finding made by a team of University of California…

UCSD-based Cancer Consortium Receives 5-Year, $20 Million Grant Renewal

September 27, 2012

An international consortium of scientists studying chronic lymphocytic leukemia (CLL), based at the University of California, San Diego School of Medicine, has been awarded a 5-year, $20 million grant by the National Cancer Institute, part of the National Institutes of Health. The grant is the second renewal of funding for…

Surfers and Philanthropists Unite in the Fight Against Cancer Aug. 9

July 27, 2015

A fundraiser like no other, the Luau and Legends of Surfing Invitational trades tuxedos and ballrooms for surfboards and sand. The San Diego tradition, now in its 22nd year, features a surf competition that draws scientists, community members and surf legends alike. Afterward, guests will enjoy a Hawaiian-themed luau with…

UC San Diego Named Top 10 Public University by U.S. News & World Report

September 13, 2021

U.S. News & World Report has once again named the University of California San Diego among the best colleges in the country. Released today, the U.S. News & World Report 2022 Best Colleges rankings listed UC San Diego as the nation’s eighth best public university.

Elizabeth Villa Selected as 2021 HHMI Investigator

September 23, 2021

Biological Sciences Associate Professor Elizabeth Villa has been selected as a 2021 Howard Hughes Medical Institute (HHMI) Investigator. As one of 33 scientists chosen out of pool of more than 800, Villa will receive $9 million over a seven-year HHMI Investigator term.

Blood Biopsy Reveals Unique, Targetable Genetic Alterations in Patients with Rare Cancer

August 15, 2017

Using fragments of circulating tumor DNA in blood, University of California San Diego School of Medicine researchers were able to identify theoretically targetable genetic alterations in 66 percent of patients with cancer of unknown primary (CUP), a rare disease with seven to 12 cases per 100,000 people each year.

How Pancreatic Cancer Defies Treatment

January 19, 2023

UC San Diego researchers describe how pancreatic cancer stem cells leverage a protein in a family of proteins that normally suppress tumors to instead do the opposite, boosting their resistance to conventional treatments and spurring growth.

Extrachromosomal DNA is common in human cancer and drives poor patient outcomes

August 17, 2020

The multiplication of genes located in extrachromosomal DNA that have the potential to cause cancer drives poor patient outcomes across many cancer types, according to a Nature Genetics study published Aug. 17, 2020 by a team of researchers including the University of California San Diego.

Personalizing Precision Medicine with Combination Therapies Improves Outcomes in Cancer

April 22, 2019

University of California San Diego School of Medicine researchers found that treating patients with personalized precision medicine that combined therapies to target multiple alterations improved outcomes in patients with therapy resistant cancers.

Category navigation with Social links